After surviving a stage four diagnosis, Jenn Henry is sharing her story to encourage others not to ignore the warning signs.

GeekWire Award finalists for Health Innovation of the Year are dominated by ventures that aim to outwit cancer with ...

We came across a bullish thesis on Merck & Co., Inc. (MRK) on Substack by Jimmy Investor. In this article, we will summarize ...

Moffitt Cancer Center researchers have discovered a promising new vaccine strategy for treating a specific type of breast ...

The National STEM Festival has come to D.C. this week. Four local participants joined Good Morning Washington. (7News) ...

Researchers developed an innovative nano-immune agonist that significantly improves immunotherapy outcomes for melanoma - a ...

Treatment with the T-cell immunotherapy Orca-T improved survival free of moderate-to-severe chronic graft-versus-host disease ...

During a Community Case Forum event in partnership with the Texas Society of Clinical Oncology, Natalie Vokes, MD, discussed trials of targeted agents for EGFR-mutant lung cancer.

In this interview, News Medical speaks with Olivier Negre, Chief Scientific Officer at Smart Immune, about how immunotherapy is being revolutionized.

Learn how long you'll likely receive Keytruda infusions, what factors can affect your treatment length, and what to expect after you stop treatment.

I knew I was kind of a guinea pig, but the only other option was staying at home, and I wasn’t going to make it,” Tim Story ...

Essentially, aspirin can boost the immune system’s ability to fight cancer metastasis by stopping platelets — tiny blood ...